{
    "Trade/Device Name(s)": [
        "ARIES C. difficile Assay Complete Kit",
        "ARIES C. difficile Assay Protocol File Kit",
        "ARIES C. difficile Assay Kit (24 cassettes)",
        "ARIES Stool Resuspension Kit",
        "ARIES C. difficile Assay"
    ],
    "Submitter Information": "Luminex Corporation",
    "510(k) Number": "K171441",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123998"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN",
        "OOI"
    ],
    "Summary Letter Date": "July 21, 2017",
    "Summary Letter Received Date": "May 16, 2017",
    "Submission Date": "May 15, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "Clostridium difficile toxin gene amplification assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin A gene (tcdA)",
        "Clostridium difficile toxin B gene (tcdB)"
    ],
    "Specimen Type(s)": [
        "Unpreserved, unformed stool (liquid or soft)"
    ],
    "Specimen Container(s)": [
        "Stool resuspension tube with preprocessing beads and Stool Resuspension Buffer"
    ],
    "Instrument(s)/Platform(s)": [
        "ARIES System",
        "ARIES M1 System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid extraction",
        "Fluorescent-labeled primer PCR"
    ],
    "Methodologies": [
        "Qualitative real-time PCR",
        "Genetic amplification testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Protocol file",
        "Resuspension kit"
    ],
    "Document Summary": "FDA 510(k) summary for Luminex ARIES C. difficile Assay, a qualitative real-time PCR assay for detection of toxigenic Clostridium difficile genes in stool samples.",
    "Indications for Use Summary": "A qualitative real-time PCR in vitro diagnostic test for direct detection of toxigenic Clostridium difficile nucleic acid in unpreserved, unformed stool from patients suspected of C. difficile infection, used as an aid in diagnosis.",
    "fda_folder": "Microbiology"
}